dehydroepiandrosterone sulfate has been researched along with Fatty Liver, Nonalcoholic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, MJ; Ho, HN | 1 |
| Kasayama, S; Koga, M; Mukai, M; Saibara, T; Saito, H | 1 |
1 review(s) available for dehydroepiandrosterone sulfate and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Hepatic manifestations of women with polycystic ovary syndrome.
Topics: Alanine Transaminase; Androgen Antagonists; Aspartate Aminotransferases; Contraceptives, Oral, Hormonal; Dehydroepiandrosterone Sulfate; Dyslipidemias; Exercise Therapy; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperandrogenism; Hypoglycemic Agents; Inflammation; Insulin Resistance; Metformin; Non-alcoholic Fatty Liver Disease; Obesity; Overweight; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone; Weight Loss | 2016 |
1 other study(ies) available for dehydroepiandrosterone sulfate and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Serum dehydroepiandrosterone sulphate levels in patients with non-alcoholic fatty liver disease.
Topics: Adult; Alanine Transaminase; Biomarkers; Dehydroepiandrosterone Sulfate; Fatty Liver; Humans; Male; Middle Aged; Non-alcoholic Fatty Liver Disease | 2011 |